Premier Anti-Aging Co., Ltd. (4934) AI Stock Analysis

• Market Cap: ¥5.25B
• Dividend Yield: N/A
• Average Volume (3M): 11.01K
• Price to Earnings (P/E): 42.4
• Beta (1Y): 1.03
• Revenue Growth: -19.42%
• EPS Growth: N/A
• Country: JP
• Employees: 229
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Household & Personal Products
• EPS (TTM): 4.26
• Shares Outstanding: 8,720,534
• 10 Day Avg. Volume: 8,960
• 30 Day Avg. Volume: 11,006
• PEG Ratio: -0.12
• Price to Book (P/B): 1.14
• Price to Sales (P/S): 0.47
• P/FCF Ratio: 5.22
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): 49.3
• Revenue Forecast (FY): ¥15.00B

• Rating: 52 Neutral
• Price Target: ¥608.00 ▼(-13.39% Downside)
• Action: Reiterated Date: 10/03/25
• Date: Action: Reiterated 10/03/25

The overall stock score is primarily impacted by the company's financial performance, which shows strengths in gross profit margin and balance sheet stability but is hindered by declining revenues and low profitability. Technical analysis indicates bearish momentum, further weighing down the score. Valuation is a relative strength, with a reasonable P/E ratio, but the lack of a dividend yield is a drawback.

Positive Factors

High Gross Profit Margin

A sustained gross margin of 76.65% indicates durable product-level economics and likely pricing power or premium positioning in anti-aging products. This margin buffer helps absorb SG&A volatility and supports reinvestment in R&D, marketing, or product development over the medium term.

Negative Factors

Declining Revenue Trend

A multi-year decline in top-line (most recently -7.23%) signals structural demand pressure, lost market share, or product lifecycle challenges. Persistent revenue contraction reduces scale benefits, constrains reinvestment capacity, and increases the importance of cost control to preserve margins.

Premier Anti-Aging Co., Ltd. Business Overview & Revenue Model

Company Description

Premier Anti-Aging Co., Ltd. engages in the planning, development, import/export, mail order, wholesale, and retail business of cosmetics and health foods. The company offers its cosmetic products under the DUO and CANADEL brands. It is also invol...

Read more

Premier Anti-Aging Co., Ltd. engages in the planning, development, import/export, mail order, wholesale, and retail business of cosmetics and health foods. The company offers its cosmetic products under the DUO and CANADEL brands. It is also invol...

How the Company Makes Money

Revenue is generated primarily through the sale of the company’s anti-aging-related offerings (e.g., products and/or services marketed under its brand). A more detailed breakdown of specific revenue streams (such as channel mix, product category c...

Read more

Revenue is generated primarily through the sale of the company’s anti-aging-related offerings (e.g., products and/or services marketed under its brand). A more detailed breakdown of specific revenue streams (such as channel mix, product category c...

Premier Anti-Aging Co., Ltd. Financial Statement Overview

Breakdown	Jul 2025	Jul 2024	Jul 2023	Jul 2022	Jul 2021
Income Statement
Total Revenue	16.16B	20.36B	26.40B	33.91B	32.81B
Gross Profit	12.39B	16.10B	19.24B	26.63B	26.43B
EBITDA	916.00M	390.00M	-423.24M	2.50B	4.72B
Net Income	471.00M	-1.48B	-733.97M	1.42B	2.79B
Balance Sheet
Total Assets	10.14B	11.05B	12.18B	12.30B	13.07B
Cash, Cash Equivalents and Short-Term Investments	4.66B	4.76B	4.67B	2.97B	6.06B
Total Debt	1.11B	2.44B	2.26B	1.41B	911.41M
Total Liabilities	3.53B	4.92B	4.57B	3.95B	6.17B
Stockholders Equity	6.61B	6.12B	7.61B	8.35B	6.90B
Cash Flow
Free Cash Flow	1.44B	-204.00M	2.40B	-3.35B	2.75B
Operating Cash Flow	1.47B	425.00M	2.42B	-3.32B	2.75B
Investing Cash Flow	-229.00M	-540.00M	-900.97M	-297.68M	-180.83M
Financing Cash Flow	-1.34B	183.00M	179.77M	501.62M	1.58B

Premier Anti-Aging Co., Ltd. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 702.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4934, the sentiment is Negative. The current price of 702 is below the 20-day moving average (MA) of 714.25, below the 50-day MA of 715.72, and below the 200-day MA of 782.78, indicating a bearish trend. The MACD of -30.32 indicates Positive momentum. The RSI at 30.17 is Neutral, neither overbought nor oversold. The STOCH value of 5.26 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4934.

Premier Anti-Aging Co., Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
4925	69 Neutral	¥6.80B	12.52	―	2.38%	-0.79%	―
4933	64 Neutral	¥18.88B	33.88	―	0.91%	13.12%	27.53%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
4926	58 Neutral	¥5.69B	-33.12	―	1.68%	8.46%	―
4936	58 Neutral	¥7.79B	-49.92	―	2.65%	11.87%	-31.02%
4934	52 Neutral	¥5.25B	42.42	―	―	-19.42%	―
4918	51 Neutral	¥2.00B	-3.04	―	―	12.96%	―

Premier Anti-Aging Co., Ltd. Corporate Events